CN Patent

CN102552263A — 提高内源性红细胞生成素(epo)的方法

Assigned to Fibrogen Inc · Expires 2012-07-11 · 14y expired

What this patent protects

本发明涉及通过提高体内和体外内源性红细胞生成素来治疗红细胞生成素相关疾病的方法。还包括治疗、预治疗或预调理、或者预防红细胞生成素相关疾病的方法。提供用于这些方法的化合物和鉴定这些化合物的方法。

USPTO Abstract

本发明涉及通过提高体内和体外内源性红细胞生成素来治疗红细胞生成素相关疾病的方法。还包括治疗、预治疗或预调理、或者预防红细胞生成素相关疾病的方法。提供用于这些方法的化合物和鉴定这些化合物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102552263A
Jurisdiction
CN
Classification
—
Expires
2012-07-11
Drug substance claim
No
Drug product claim
No
Assignee
Fibrogen Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.